Remote Hypertension Management for Black Patients
Launched by WAKE FOREST UNIVERSITY HEALTH SCIENCES · Jul 25, 2024
Trial Information
Current as of June 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Remote Hypertension Management for Black Patients," is exploring two different ways to help Black patients manage their high blood pressure, which is also known as hypertension. One method involves using a home blood pressure monitor along with support from a pharmacist and a community health worker, while the other method provides regular care at a clinic, along with a home monitor. The study aims to see which approach is more effective in controlling blood pressure for those who struggle with it.
To be eligible for this study, participants must identify as Black or African American, be between the ages of 21 and 85, and have a diagnosis of uncontrolled hypertension, which means their blood pressure readings are consistently high. Participants should also be able to communicate in English and receive their primary care from a participating clinic. If you join the study, you can expect regular follow-ups, support from healthcare professionals, and the opportunity to contribute to finding better ways to manage hypertension in your community. It’s important to note that this study is not for pregnant individuals or those living in long-term care facilities.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Black or African American race
- • Hypertension diagnosis
- • aged 21 to 85 years
- • Uncontrolled blood pressure as defined by \[a\] most recent SBP ≥140 mmHg and an additional SBP≥140 mmHg within the past 12 months in an outpatient setting (excluding urgent care, emergency department or surgery clinic), or \[b\] most recent SBP\>160mmHg in an outpatient setting (excluding urgent care, emergency department or surgery clinic), or \[c\] referral by PCP for uncontrolled hypertension with at least one documented SBP≥140 mmHg (in clinic or at home) in the past 12 months; and (v) primary care provided at a participating clinic.
- • Able to speak English
- • Primary care provided at a participating clinic
- Exclusion Criteria:
- • currently pregnant or planning to get pregnant during the study period
- • residence in a long-term care facility, hospice or with a terminal illness with less than 1 year life expectancy as determined by the Primary Care Physician or study team. Stable chronic illness such as compensated cirrhosis, chronic obstructive pulmonary disease, congestive heart failure etc. will not be excluded.
- • estimated Glomerular Filtration Rate (eGFR) \<30 ml/min or on dialysis. Patients with a functioning kidney transplant will not be excluded.
- • inability to provide informed consent or participate in study procedures. For example, conditions that limit ability to participate in phone visits or check BPs in at least one arm.
- • currently participating in another BP management program.
- • plan to move out of the area within the next 12 months.
- • Hispanic ethnicity.
About Wake Forest University Health Sciences
Wake Forest University Health Sciences is a leading academic research institution dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on multidisciplinary collaboration, the organization leverages its extensive expertise in medical research, patient care, and education to develop and evaluate new therapies and interventions. Committed to improving patient outcomes and public health, Wake Forest University Health Sciences fosters a dynamic environment for scientific inquiry, engaging in a wide range of clinical studies that address pressing health challenges. Through its rigorous methodologies and ethical standards, the institution aims to contribute significantly to the medical field and enhance the quality of life for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Winston Salem, North Carolina, United States
Patients applied
Trial Officials
Yhenneko J. Taylor, PhD
Principal Investigator
Wake Forest University Health Sciences
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported